[Evaluation of compliance with prescription proposals for COPD in the Alsace region of France].

IF 0.5 4区医学 Q4 RESPIRATORY SYSTEM

Revue des maladies respiratoires Pub Date : 2025-03-31 DOI:10.1016/j.rmr.2025.03.002

T Grosz, G Calcaianu, C Palpacuer, M Riou, L Kassegne, C Marcot, T Degot, J Leroux, L Kalmuk, M Fore, R Kessler, B Renaud-Picard

{"title":"[Evaluation of compliance with prescription proposals for COPD in the Alsace region of France].","authors":"T Grosz, G Calcaianu, C Palpacuer, M Riou, L Kassegne, C Marcot, T Degot, J Leroux, L Kalmuk, M Fore, R Kessler, B Renaud-Picard","doi":"10.1016/j.rmr.2025.03.002","DOIUrl":null,"url":null,"abstract":"Introduction: The use of inhaled treatments for chronic obstructive pulmonary disease (COPD) in France follows the management proposals issued by the Société de Pneumologie de Langue Française (SPLF). We conducted a retrospective study in two hospitals in Alsace, France to determine the rate of compliance with the recommended treatments.Methods: Data were collected from patients with follow-up for COPD between August 2022 and January 2023. Asthma-COPD Overlap and Overlap syndrome phenotypes were excluded from the study. The data were extracted from the patient's most recent pulmonology consultation at one of the two centers.Results: Out of the 250 patients recruited, 183 (73.2%) had compliant prescriptions. Among those with non-compliant prescriptions, 38 exhibited over-prescribing (56.7%), often secondary to inappropriate use of inhaled corticosteroids (ICS), while 29 cases showed under-prescribing (43.3%), due mainly to lack of treatment with long-acting bronchodilators.Conclusions: Treatment prescription in COPD remains sub-optimal, with a high proportion of therapeutic non-conformities, especially the over-prescribing of ICS. Further studies are needed to develop strategies for improving prescribing practices.","PeriodicalId":21548,"journal":{"name":"Revue des maladies respiratoires","volume":" ","pages":""},"PeriodicalIF":0.5000,"publicationDate":"2025-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revue des maladies respiratoires","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.rmr.2025.03.002","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}

引用次数: 0

Abstract

Introduction: The use of inhaled treatments for chronic obstructive pulmonary disease (COPD) in France follows the management proposals issued by the Société de Pneumologie de Langue Française (SPLF). We conducted a retrospective study in two hospitals in Alsace, France to determine the rate of compliance with the recommended treatments.

Methods: Data were collected from patients with follow-up for COPD between August 2022 and January 2023. Asthma-COPD Overlap and Overlap syndrome phenotypes were excluded from the study. The data were extracted from the patient's most recent pulmonology consultation at one of the two centers.

Results: Out of the 250 patients recruited, 183 (73.2%) had compliant prescriptions. Among those with non-compliant prescriptions, 38 exhibited over-prescribing (56.7%), often secondary to inappropriate use of inhaled corticosteroids (ICS), while 29 cases showed under-prescribing (43.3%), due mainly to lack of treatment with long-acting bronchodilators.

Conclusions: Treatment prescription in COPD remains sub-optimal, with a high proportion of therapeutic non-conformities, especially the over-prescribing of ICS. Further studies are needed to develop strategies for improving prescribing practices.

查看原文本刊更多论文

求助全文

约1分钟内获得全文求助全文

来源期刊

Revue des maladies respiratoires 医学-呼吸系统

CiteScore

1.10

自引率

16.70%

发文量

168

审稿时长

4-8 weeks

期刊介绍： La Revue des Maladies Respiratoires est l''organe officiel d''expression scientifique de la Société de Pneumologie de Langue Française (SPLF). Il s''agit d''un média professionnel francophone, à vocation internationale et accessible ici. La Revue des Maladies Respiratoires est un outil de formation professionnelle post-universitaire pour l''ensemble de la communauté pneumologique francophone. Elle publie sur son site différentes variétés d''articles scientifiques concernant la Pneumologie : - Editoriaux, - Articles originaux, - Revues générales, - Articles de synthèses, - Recommandations d''experts et textes de consensus, - Séries thématiques, - Cas cliniques, - Articles « images et diagnostics », - Fiches techniques, - Lettres à la rédaction.